Genmab
Dr. Van Vugt started her professional career at Genmab in 2001 and was appointed Senior Vice President in 2014. Previously, she was responsible for Genmab’s Project and Alliance Management, as well as strategic initiatives and will continue overseeing these areas. Since 2011 she has been active in Business Development. She is listed as inventor on numerous patents and has been involved in the completion of many partnership and research deals between Genmab and big pharma/biotech companies. She holds an M.Sc. degree from the University of Wageningen and a Ph.D. degree from Utrecht University.
This person is not in any teams
This person is not in any offices
Genmab
40 followers
Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.